Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid
Enantiomerically pure pipecolic acid derivatives were prepared and introduced in constrained dipeptoids instead of their proline equivalents. This led to new CCK-B antagonists. Structural analyses performed on both series provided information about the bioactive conformation of the dipeptoids.
References (18)
- et al.
Peptides
(1994) - et al.
Biochem. Biophys. Res. Commun.
(1986) - et al.
Pharmacol. Biochem. Behav.
(1994) - et al.
Tetrahedron
(1996) - et al.
Bioorg. Med. Chem. Lett.
(1995) - et al.
J. Bioorg. Med. Chem. Lett.
(1996) - et al.
Bioorg. Med. Chem. Lett.
(1994) - et al.
Clin. Exp. Pharm. Pharmacol.
(1997)
There are more references available in the full text version of this article.
Cited by (29)
Recent advancements on the synthesis and biological significance of pipecolic acid and its derivatives
2022, Journal of Molecular StructureStereoselective syntheses of 4-fluoro- and 4,4-difluoropipecolic acids
2001, Tetrahedron LettersSynthesis of (2R,4R)- and (2S,4S)-4-hydroxypipecolic acid derivatives and (2S,4S)-(-)-SS20846A
2001, Tetrahedron LettersCCK-B receptor: Chemistry, molecular biology, biochemistry and pharmacology
1999, Progress in Neurobiology
- 1
Fax. (33)-1-43.26.69.18.
Copyright © 1998 Published by Elsevier Ltd.